Is Annexon Inc (ANNX) overvalued? · $268.1M cap
Annexon Inc (ANNX) is a biotechnology company listed on US.
This page asks whether Annexon Inc (ANNX) looks expensive on cached numbers — not a short thesis.
No cached income statement for ANNX, so there is no earnings base to call rich or cheap.
ANNX currently screens at market cap $268.1M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ANNX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ANNX stock page for the full model, not this heading.
Not investment advice.